Greenwood Capital Associates LLC Avid Bioservices, Inc. Transaction History

Greenwood Capital Associates LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$9.4 - $14.04 $258,434 - $386,001	-27,493 Reduced 46.85%	31,188 $294,000
Q2 2023 Aug 07, 2023	SELL	$12.96 - $20.93 $115,240 - $186,109	-8,892 Reduced 13.16%	58,681 $819,000
Q1 2023 May 12, 2023	SELL	$13.48 - $18.79 $34,845 - $48,572	-2,585 Reduced 3.68%	67,573 $1.27 Million
Q4 2022 Jan 26, 2023	BUY	$12.61 - $18.74 $88,408 - $131,386	7,011 Added 11.1%	70,158 $0
Q3 2022 Nov 10, 2022	SELL	$15.33 - $20.36 $13,720 - $18,222	-895 Reduced 1.4%	63,147 $1.21 Million
Q2 2022 Aug 10, 2022	SELL	$11.63 - $21.55 $62,836 - $116,434	-5,403 Reduced 7.78%	64,042 $977,000
Q1 2022 May 10, 2022	BUY	$16.63 - $27.73 $71,509 - $119,239	4,300 Added 6.6%	69,445 $1.42 Million
Q4 2021 Feb 03, 2022	SELL	$20.7 - $34.18 $357,944 - $591,040	-17,292 Reduced 20.98%	65,145 $1.9 Million
Q3 2021 Oct 27, 2021	BUY	$19.05 - $28.32 $971 - $1,444	51 Added 0.06%	82,437 $1.78 Million
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $18,797 - $25,470	-993 Reduced 1.19%	82,386 $2.11 Million
Q1 2021 May 14, 2021	SELL	$11.86 - $21.77 $86,151 - $158,137	-7,264 Reduced 8.01%	83,379 $1.52 Million
Q4 2020 Feb 09, 2021	BUY	$7.25 - $11.76 $159,253 - $258,320	21,966 Added 31.98%	90,643 $1.05 Million
Q3 2020 Nov 12, 2020	BUY	$6.53 - $8.6 $448,460 - $590,622	68,677 New	68,677 $523,000

209

67.1M

216K

4.6K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.